As shown in the figures, a significant decrease was observed in the expression of MID1IP1, CYP2C9, CPT2, CRAT, TP53INP2, FAAH2, and PTPRG, while a moderate increase in the expression of ABCD1 was observed in the ccRCC samples. This evidence concerns the gene CPT2 and nonpapillary renal cell carcinoma.